Givaudan | GIVN - Cash And Equivalent


Givaudan reported CHF603M in Cash and Equivalent for its fiscal semester ending in June of 2024.





Cash And Equivalent Change Date
Air Liquide EUR 3.96B 2.05B Dec/2025
Akzo Nobel EUR 2.76B 1.14B Mar/2026
Anheuser-Busch USD 11.53B 4.47B Dec/2025
Arkema EUR 1.73B 458.1M Mar/2026
Associated British Foods GBP 1.06B 299M Jun/2025
BASF EUR 7.8B 4.71B Jun/2026
Bayer EUR 4.29B 1.44B Jun/2026
Beiersdorf EUR 1.2B 33M Dec/2025
British American Tobacco GBP 2.52B 974M Jun/2026
Covestro EUR 648M 44M Dec/2025
Croda International GBP 157.8M 9M Jun/2025
Danone EUR 1.98B 364M Dec/2025
Diageo GBP 2.21B 9M Dec/2025
Fresenius EUR 2.06B 752M Mar/2026
Fresenius Medical Care EUR 1.06B 177.89M Jun/2026
Givaudan CHF 603M 3M Jun/2024
Glanbia EUR 417M 116.1M Jan/2025
Heineken EUR 2.07B 284M Jun/2025
Henkel EUR 2.71B 163M Dec/2025
International Flavors Fragrances USD 569M 7M Jun/2026
Johnson Matthey GBP 542M 49M Jun/2024
Kerry EUR 348.9M 594.8M Dec/2025
Lonza CHF 719M 188M Dec/2025
L'Oréal EUR 4.05B 5.82B Jun/2026
Merck EUR 2.74B 415M Mar/2026
Nestle CHF 3.55B 1.03B Jun/2026
Pernod Ricard EUR 2.4B 569M Dec/2025
Reckitt Benckiser GBP 880M 106M Dec/2024
SGS CHF 1.21B 78M Dec/2024
Sika AG CHF 1.87B 1.18B Dec/2022
Solvay EUR 367M 119M Jun/2026
Tate & Lyle GBP 475M 41M Jun/2023
Umicore EUR 1.56B 450.17M Dec/2025
Victrex GBP 58.7M 13M Dec/2022